A61K 9/4875
Compounds of unknown constitution
Official title: {Compounds of unknown constitution, e.g. material from plants or animals (oils, fats, waxes, shellac A61K9/4858)}
A61K9/4875 (Compounds of unknown constitution) appears on 381 US grants and 738 published applications in this corpus.
Search patents in A61K- Granted patents
- 381
- Published applications
- 738
- Assignees
- 305
- Inventors
- 981
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 2 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 3 |
| 2004 | 2 | 5 |
| 2005 | 2 | 3 |
| 2006 | 3 | 8 |
| 2007 | 3 | 12 |
| 2008 | 3 | 12 |
| 2009 | 0 | 15 |
| 2010 | 3 | 13 |
| 2011 | 4 | 11 |
| 2012 | 7 | 15 |
| 2013 | 11 | 26 |
| 2014 | 12 | 27 |
| 2015 | 20 | 59 |
| 2016 | 22 | 62 |
| 2017 | 26 | 58 |
| 2018 | 35 | 60 |
| 2019 | 40 | 65 |
| 2020 | 37 | 47 |
| 2021 | 40 | 65 |
| 2022 | 26 | 32 |
| 2023 | 24 | 37 |
| 2024 | 19 | 57 |
| 2025 | 26 | 29 |
| 2026 | 13 | 17 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Compositions for modulating gut microflora populations, enhancing drug potency and treating cancer, and methods for making and using same25 Aug 2026US 12,714,730 B2Persephone Biosciences, Inc.
- Compositions and methods for treating diabetes28 Jul 2026US 12,691,163 B2Poviva Corp.
- Controlled release concentrate and suspensions including the same16 Jun 2026US 12,653,782 B2Nulixir Inc.
- Pharmaceutical formulations comprising tadalafil14 Apr 2026US 12,599,554 B2KYDES Pharmaceuticals LLC
- Lactobacillus plantarum ZUST49 and bacterial agent, and use thereof14 Apr 2026US 12,599,640 B2Zhejiang University of Science and Technology
- Composition for oral use with hmg-coa reductase enzyme inhibiting activity1 Oct 2026US 2026/0294995 A1Difass International S.P.A.
- Lactobacillus compositions for treating type 2 diabetes24 Sep 2026US 2026/0284126 A1
- Fenofibrate-based oily formulation, oral medicine, and preparation method thereof13 Aug 2026US 2026/0232615 A1Innovation Center of Yangtze River Delta, Zhejiang University
- Oral polypeptide composition and use thereof23 Jul 2026US 2026/0207712 A1Hefei Tianhui Biotech Co., Ltd.
- Oral Brexanolone Compositions and Methods of Preparation and Use16 Jul 2026US 2026/0199372 A1Lipocine Inc.
Most cited
By later US patents
- Pharmaceutical formulation containing gelling agent198US 8,337,888 B2Purdue Pharma L. P. · 2012
- Pharmaceutical composition containing gelling agent96US 8,389,007 B2Purdue Pharma L. P. · 2013
- Pharmaceutical formulation containing gelling agent87US 8,609,683 B2Purdue Pharma L. P. · 2013
- Pharmaceutical formulation containing gelling agent82US 8,529,948 B1Purdue Pharma L. P. · 2013
- Pharmaceutical formulation containing gelling agent76US 9,060,976 B2Purdue Pharma L. P. · 2015